REGN Sale Disclosure
Poon Christine A · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$2.42M
Poon Christine A Director
REGN
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
REGN daily price context
Close on/before transaction
$961.26
Nov 2, 2026
First close after public filing
$902.9
Nov 5, 2026
Return after filing · so far
+0.16%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,499 shares @ $968.58
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001189014-26-000009
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$10.54M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $210.75K |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $909.37K |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $195.23K |
| Regeneron Pharmaceuticals, Inc. REGN Current | Sale | Nov 2, 2026 | $2.42M |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $746.82K |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 2, 2026 | $0 |
| Regeneron Pharmaceuticals, Inc. REGN | Exercise | Nov 2, 2026 | $2.95M |
| Regeneron Pharmaceuticals, Inc. REGN | Sale | Nov 2, 2026 | $3.11M |